ElMindA Ltd   Report issue

For profit Phase 4
Founded: Herzliya Israel (2006)

Organization Overview

First Clinical Trial
2009
NCT01063153
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now